Oarsman Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.86M Buy
19,140
+232
+1% +$54.1K 0.51% 34
2026
Q1
$4.62M Buy
18,908
+860
+5% +$200K 0.57% 29
2025
Q4
$3.73M Sell
18,048
-472
-3% -$93.3K 0.48% 36
2025
Q3
$3.43M Buy
18,520
+851
+5% +$146K 0.48% 36
2025
Q2
$2.7M Buy
17,669
+97
+0.6% +$14.9K 0.42% 44
2025
Q1
$2.91M Buy
17,572
+575
+3% +$90K 0.52% 35
2024
Q4
$2.46M Buy
16,997
+37
+0.2% +$5.73K 0.43% 43
2024
Q3
$2.75M Buy
16,960
+181
+1% +$28.8K 0.51% 37
2024
Q2
$2.45M Buy
16,779
+449
+3% +$66.8K 0.54% 36
2024
Q1
$2.58M Sell
16,330
-2,014
-11% -$321K 0.62% 36
2023
Q4
$2.88M Buy
18,344
+373
+2% +$57.2K 0.76% 30
2023
Q3
$2.8M Sell
17,971
-3,184
-15% -$525K 1.17% 19
2023
Q2
$3.5M Sell
21,155
-2,641
-11% -$426K 1.53% 14
2023
Q1
$3.69M Buy
23,796
+2,763
+13% +$446K 1.72% 14
2022
Q4
$3.72M Buy
21,033
+158
+0.8% +$27.3K 1.9% 14
2022
Q3
$3.41M Sell
20,875
-178
-0.8% -$30.1K 1.83% 13
2022
Q2
$3.74M Sell
21,053
-658
-3% -$117K 1.86% 12
2022
Q1
$3.85M Buy
21,711
+770
+4% +$131K 1.5% 15
2021
Q4
$3.58M Sell
20,941
-715
-3% -$117K 1.41% 15
2021
Q3
$3.5M Sell
21,656
-2,577
-11% -$440K 1.42% 12
2021
Q2
$3.99M Sell
24,233
-2,809
-10% -$465K 1.59% 11
2021
Q1
$4.44M Sell
27,042
-3,514
-12% -$569K 1.92% 9
2020
Q4
$4.81M Sell
30,556
-977
-3% -$144K 1.87% 9
2020
Q3
$4.7M Buy
31,533
+232
+0.7% +$34.3K 2.12% 8
2020
Q2
$4.4M Buy
31,301
+11,058
+55% +$1.61M 2.18% 7
2020
Q1
$2.65M Sell
20,243
-11,933
-37% -$1.69M 2.45% 8
2019
Q4
$4.69M Sell
32,176
-532
-2% -$72.2K 2.15% 7
2019
Q3
$4.23M Buy
32,708
+533
+2% +$70.2K 2.01% 8
2019
Q2
$4.48M Buy
32,175
+600
+2% +$83.1K 2.03% 9
2019
Q1
$4.41M Buy
31,575
+452
+1% +$60.5K 2.1% 7
2018
Q4
$4.02M Buy
31,123
+783
+3% +$109K 2.06% 8
2018
Q3
$4.19M Buy
30,340
+853
+3% +$113K 1.69% 14
2018
Q2
$3.58M Buy
29,487
+423
+1% +$52.8K 1.63% 15
2018
Q1
$3.73M Buy
29,064
+570
+2% +$77K 1.7% 15
2017
Q4
$3.98M Sell
28,494
-479
-2% -$66.7K 1.71% 12
2017
Q3
$3.77M Buy
28,973
+288
+1% +$38.2K 1.59% 16
2017
Q2
$3.79M Sell
28,685
-1,477
-5% -$188K 1.74% 10
2017
Q1
$3.76M Buy
30,162
+11,147
+59% +$1.33M 1.75% 11
2016
Q4
$2.19M Sell
19,015
-10,791
-36% -$1.25M 1.41% 20
2016
Q3
$3.52M Sell
29,806
-393
-1% -$47.7K 1.8% 9
2016
Q2
$3.66M Sell
30,199
-412
-1% -$46.8K 1.9% 8
2016
Q1
$3.31M Sell
30,611
-367
-1% -$38K 1.76% 7
2015
Q4
$3.18M Sell
30,978
-292
-0.9% -$29.4K 1.78% 7
2015
Q3
$2.92M Buy
31,270
+184
+0.6% +$17.8K 1.73% 7
2015
Q2
$3.03M Buy
31,086
+198
+0.6% +$19.8K 2.07% 4
2015
Q1
$3.11M Buy
30,888
+1,193
+4% +$121K 2.15% 4
2014
Q4
$3.1M Sell
29,695
-443
-1% -$46.7K 2.24% 3
2014
Q3
$3.21M Sell
30,138
-117
-0.4% -$12.1K 2.37% 2
2014
Q2
$3.17M Sell
30,255
-207
-0.7% -$20.9K 2.3% 3
2014
Q1
$2.99M Sell
30,462
-19
-0.1% -$1.76K 2.31% 3
2013
Q4
$2.79M Buy
30,481
+182
+0.6% +$16.8K 2.24% 2
2013
Q3
$2.63M Buy
30,299
+226
+0.8% +$20.3K 2.29% 2
2013
Q2
$2.58M Buy
+30,073
New +$2.55M 2.44% 2

Other funds holding JNJ

Oarsman Capital's JNJ Position: Q2 2026 in Review

Oarsman Capital increased its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, buying an estimated $54.1K and bringing the position to 19,140 shares worth $4.86M. The position accounts for 0.51% of the portfolio, ranked #34.

Oarsman Capital first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Oarsman Capital held 19,140 shares of Johnson & Johnson worth $4.86M as of Q2 2026.
  • Oarsman Capital bought 232 Johnson & Johnson shares in Q2 2026, an estimated $54.1K.
  • Johnson & Johnson made up 0.51% of Oarsman Capital's portfolio in Q2 2026, its #34 holding.
  • Oarsman Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.